This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, ...

Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternativesNEW ...

Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock reserves for incentive plans, according to a filing with the Securities ...

DelveInsight's“Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the ...

Inc., a pharmaceutical company specializing in preparations, has entered into a significant agreement that has led to the ...

Eyenovia, Inc. announced on January 15, 2025, that leading proxy advisory firms ISS and Glass Lewis have advised stockholders to vote in favor of a proposed reverse stock split at a ratio between ...

Eyenovia (EYEN) announced that the two leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co., have recommended that Eyenovia stockholders entitled to ...